Derivatives of laspartomycin and preparation and use thereof

Details for Australian Patent Application No. 2001275943 (hide)

International Classifications

Event Publications

4 December 2003 Assignment before Grant

Intrabiotics Pharmaceuticals, Inc. The application has been assigned to Micrologix Biotech Inc. Assignments before Grant, Section 113

6 April 2006 Application Accepted

Published as AU-B-2001275943

13 July 2006 Change of Name(s) of Applicant(s), Section 104

Micrologix Biotech Inc. The name of the applicant has been changed to Migenix Inc. 2002

3 August 2006 Standard Patent Sealed

31 March 2011 Assignment Registered

Migenix Inc. The patent has been assigned to BioSource Pharm, Inc.

9 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.